VEGFA and osteosarcoma: Given the limited current histological evidence for osteosarcoma prognosis, these biomarkers can be used for the prognosis and treatment of osteosarcoma by proving the association between HER-2neu and VEGF expression and osteosarcoma (Zhou et al., 2003).